Neogen Corp (FRA:NG2)
€ 15 0.6 (4.17%) Market Cap: 3.32 Bil Enterprise Value: 4.04 Bil PE Ratio: 0 PB Ratio: 1.13 GF Score: 76/100

Neogen Corp at Piper Sandler Healthcare Conference Transcript

Nov 30, 2022 / 01:00PM GMT
Release Date Price: €14.8 (+2.07%)
David Westenberg
Piper Sandler & Co. - Analyst

Thank you, everybody, for joining us, and thank you, John, for coming here, we'll just skip this one. Let's start off with -- you made a big acquisition in 3M, biggest acquisition in the company's history, in my opinion, something that fits very well with the overall portfolio.

Questions & Answers

David Westenberg
Piper Sandler & Co. - Analyst

Now, we're looking at guidance that you gave in December of about - I think it was $1 billion in revenue and $300 million in EBITDA. Can you talk about where we're tracking relative to that, and if you have any -- maybe updated expectations around what you think that business can do now that you've seen it?

John Adent
Neogen Corporation - CEO & President

Yeah. Sure, David. Thanks. So 90 days in. Pretty excited. Things were going really, really well. The world changed from December of last year till today. We've got now, war in Ukraine, we've got the recession, we've got some other things. So when you think

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot